Anemia, a common hematological disorder, presents a diagnostic challenge due to its multifactorial etiology. This article aims to simplify the diagnostic approach for healthcare professionals.
Anemia is broadly classified based on the Mean Corpuscular Volume (MCV). Microcytic anemia is often due to iron deficiency or thalassemia. Normocytic anemia might indicate chronic disease, while macrocytic anemia could suggest vitamin B12 or folate deficiency.
Initial evaluation includes a complete blood count and reticulocyte count. If MCV is low, iron studies or hemoglobin electrophoresis can be undertaken. For normal MCV, serum creatinine and erythrocyte sedimentation rate tests are beneficial. In case of high MCV, serum B12 and folate levels should be assessed.
Unexplained or severe anemia may warrant bone marrow examination. Genetic testing is useful in suspected hereditary anemias. Other advanced investigations include endoscopy, colonoscopy, or computed tomography scans to identify potential sources of blood loss.
Diagnosing anemia requires a systematic approach, starting with an etiological classification followed by targeted investigations. Understanding the complexity of anemia is essential for effective patient management and treatment.
1.
NPM1-Mutated AML: Not All Treatments Are Equal
2.
Paging Dr. AI; Myth Busting in Cancer; Oncologists Shine in Malpractice Survey
3.
MRI can save rectal cancer patients from surgery, study suggests
4.
Rectal Cancer 'Crisis'; Smells Like Cancer; Flushing Away Clues to Colon Cancer
5.
Rising rates of head and neck cancers in England
1.
A Closer Look at Breast Cancer: Examining the Ultrasound Images
2.
Exploring the Latest Advances in Hodgkin's Lymphoma Treatment
3.
Molecular Classification of Refractory Anemia: A Comprehensive Review
4.
Ferroptosis-Modulating Therapeutics in Precision Oncology
5.
Blood-Cell Morphology Foundation Models: Transforming Hematological Diagnostics and Clinical Practice
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World
2.
Thromboprophylaxis In Medical Settings- An Update
3.
Nimotozumab Plus Chemo-radiotherapy v/s Placebo Plus Chemo-radiotherapy in Locally Advanced Nasopharyngeal Carcinoma
4.
How Platelet Disorders Can Affect the Body
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation